
Marcelo Negrao/X
Jan 17, 2025, 14:52
Marcelo Negrao: Co-mutations and transcriptional signatures in non-small cell lung cancer patients
Marcelo Negrao, Assistant Professor of Medical Oncology at MD Anderson Cancer Center, shared his recent article on LinkedIn:
“Excited to see our manuscript published AACR – excellent example of team work to improve outcomes for lung patients.
Impact of co-mutations and transcriptional signatures in non-small cell lung cancer patients treated with adagrasib in the KRYSTAL-1 trial.”
Impact of co-mutations and transcriptional signatures in non-small cell lung cancer patients treated with adagrasib in the KRYSTAL-1 trial.
Authors: Marcelo V. Negrao, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 15:06
Feb 21, 2025, 14:27
Feb 21, 2025, 14:13
Feb 21, 2025, 13:29